Roman Perez-Soler
Director/Miembro de la Junta en Albert Einstein Cancer Center .
Perfil
Roman Perez-Soler was the founder of Transave, Inc. (founded in 1997) where he held the title of Director.
Dr. Perez-Soler is also the founder of Aronex Pharmaceuticals, Inc., Argus Pharmaceuticals, Inc., and Stelexis Therapeutics LLC.
Dr. Perez-Soler's current job is as Deputy Director at Albert Einstein Cancer Center.
Dr. Perez-Soler's former jobs include being an Independent Director at Adgero Biopharmaceuticals Holdings, Inc., a Professor at Montefiore Medical Center, and a Scientific Advisor at Easton Capital Investment Group.
Dr. Perez-Soler obtained a doctorate degree from Universitat Autònoma de Barcelona in 1977.
Dr. Perez-Soler is also the founder of Aronex Pharmaceuticals, Inc., Argus Pharmaceuticals, Inc., Stelexis Therapeutics LLC.
Cargos activos de Roman Perez-Soler
Empresas | Cargo | Inicio |
---|---|---|
Albert Einstein Cancer Center | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Roman Perez-Soler.
Empresas | Cargo | Fin |
---|---|---|
Argus Pharmaceuticals, Inc. | Fundador | - |
Stelexis Therapeutics LLC
Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | Fundador | - |
Montefiore Medical Center
Montefiore Medical Center Miscellaneous Commercial ServicesCommercial Services Montefiore Medical Center engages in the provision of healthcare, clinical and surgical services. It offers treatments including cardiology and cardiac surgery, cancer care, tissue and organ transplantation, children’s health, women’s health, surgery and the surgical subspecialties. The company was founded in 1884 and is headquartered in Bronx, NY. | Corporate Officer/Principal | - |
Adgero Biopharmaceuticals Holdings, Inc.
Adgero Biopharmaceuticals Holdings, Inc. Medical SpecialtiesHealth Technology Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ. | Director/Miembro de la Junta | - |
Aronex Pharmaceuticals, Inc.
Aronex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aronex Pharmaceuticals, Inc. develops proprietary medicines to treat cancer and infectious diseases. The company's products include Nyotran, Atragen, Annamycin, and Zintevir. It is headquartered in The Woodlands, TX. | Corporate Officer/Principal | - |
Formación de Roman Perez-Soler.
Universitat Autònoma de Barcelona | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 8 |
---|---|
Aronex Pharmaceuticals, Inc.
Aronex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aronex Pharmaceuticals, Inc. develops proprietary medicines to treat cancer and infectious diseases. The company's products include Nyotran, Atragen, Annamycin, and Zintevir. It is headquartered in The Woodlands, TX. | Health Technology |
Argus Pharmaceuticals, Inc. | Health Technology |
Transave, Inc.
Transave, Inc. Pharmaceuticals: MajorHealth Technology Transave, Inc. is a biopharmaceutical company focused on developing innovative, inhaled pharmaceuticals for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. They are committed to significantly improving the quality of life and healthcare of patients suffering from these life-threatening diseases. Its operating principles are centered on teamwork, openness, mutual respect, diversity of opinion, trust, accountability and innovative science. They are developing products based on Transave's proprietary liposomal technology designed specifically for lung delivery. Its focus is on reformulating off-patent, established drugs into unique liposomal technology - based inhaled pharmaceuticals for the localized, site-specific treatment of serious lung diseases. Transave's proprietary liposomal technology allows for the sustained release of a drug in the lung's microenvironment. By remaining in the lungs for a prolonged period and potentially minimizing systemic exposure, Transave's liposomal technology offers the potential for changing the product profile, improving delivery of the compound to the lung and enhancing the therapeutic index of established pharmaceuticals. | Health Technology |
Montefiore Medical Center
Montefiore Medical Center Miscellaneous Commercial ServicesCommercial Services Montefiore Medical Center engages in the provision of healthcare, clinical and surgical services. It offers treatments including cardiology and cardiac surgery, cancer care, tissue and organ transplantation, children’s health, women’s health, surgery and the surgical subspecialties. The company was founded in 1884 and is headquartered in Bronx, NY. | Commercial Services |
Easton Capital Investment Group
Easton Capital Investment Group Investment ManagersFinance Easton Capital Investment Group (Easton) is a Venture Capital firm which is founded in 2000 by John H. Friedman. The firm is headquartered in New York ,US. | Finance |
Adgero Biopharmaceuticals Holdings, Inc.
Adgero Biopharmaceuticals Holdings, Inc. Medical SpecialtiesHealth Technology Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ. | Health Technology |
Albert Einstein Cancer Center | |
Stelexis Therapeutics LLC
Stelexis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Stelexis Therapeutics LLC focuses on identifying and isolating the earliest definable stem and progenitor cells, which harbor clonal properties and pre-cancerous alterations. The company was founded by Ulrich Steidl, Derrick Rossi, Amit Verma, Evripidis Gavathiotis, and Roman Perez-Soler in 2017 and is headquartered in New York ,NY. | Health Technology |
- Bolsa de valores
- Insiders
- Roman Perez-Soler